Autolus Therapeutics (AUTL) Prepaid Assets (2018 - 2025)
Autolus Therapeutics posted quarterly Prepaid Assets of $76.5 million for Q4 2025, up 13.58% year-on-year from $67.3 million in Q4 2024, and down 10.39% on a QoQ basis from $85.3 million in Q3 2025.
Autolus Therapeutics (AUTL) has 8 years of Prepaid Assets data on file, last reported at $76.5 million in Q4 2025.
- For the quarter ending Q4 2025, Prepaid Assets rose 13.58% year-over-year to $76.5 million; the trailing twelve-month figure through Dec 2025 stood at $76.5 million (up 13.58% YoY), and the FY2025 full-year result was $76.5 million, up 13.58% from the prior year.
- Prepaid Assets for Q4 2025 stood at $76.5 million, down from $85.3 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $85.3 million in Q3 2025 and bottomed at -$22.7 million in Q3 2021.
- The 5-year median for Prepaid Assets is $44.8 million (2024), against an average of $30.8 million.
- The widest annual swing landed in 2021, when Prepaid Assets slumped 145.15%; it then surged 3345.82% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $36.3 million in 2021, then plunged by 99.44% to $203000.0 in 2022, then soared by 25285.71% to $51.5 million in 2023, then jumped by 30.65% to $67.3 million in 2024, then increased by 13.58% to $76.5 million in 2025.
- The last three Prepaid Assets figures came in at $76.5 million (Q4 2025), $85.3 million (Q3 2025), and $67.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 76.47 Mn |
| Sep 30, 2025 | 85.34 Mn |
| Jun 30, 2025 | 67.88 Mn |
| Mar 31, 2025 | 1.62 Mn |
| Dec 31, 2024 | 67.33 Mn |
| Sep 30, 2024 | 59.58 Mn |
| Jun 30, 2024 | 51.64 Mn |
| Mar 31, 2024 | 44.75 Mn |
| Sep 30, 2023 | 51.53 Mn |
| Jun 30, 2023 | -1.59 Mn |
| Mar 31, 2023 | -5.89 Mn |
| Dec 31, 2022 | 203,000.00 |
| Sep 30, 2022 | 48.94 Mn |
| Jun 30, 2022 | -10.10 Mn |
| Mar 31, 2022 | -5.43 Mn |
| Dec 31, 2021 | 36.28 Mn |
| Sep 30, 2021 | -22.75 Mn |
| Jun 30, 2021 | -9.53 Mn |
| Mar 31, 2021 | 48.26 Mn |
| Dec 31, 2020 | 42.90 Mn |
| Sep 30, 2020 | 50.39 Mn |
| Jun 30, 2020 | 35.90 Mn |
| Mar 31, 2020 | 36.84 Mn |
| Dec 31, 2019 | 37.83 Mn |
| Sep 30, 2019 | -15.84 Mn |
| Jun 30, 2019 | 25.83 Mn |
| Mar 31, 2019 | -6.82 Mn |
| Dec 31, 2018 | 15.41 Mn |
| Sep 30, 2018 | -5.76 Mn |
| Jun 30, 2018 | -4.86 Mn |